BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19680686)

  • 1. Adhesion molecules and p16 expression in endocervical adenocarcinoma.
    Carico E; Fulciniti F; Giovagnoli MR; Losito NS; Botti G; Benincasa G; Farnetano MG; Vecchione A
    Virchows Arch; 2009 Sep; 455(3):245-51. PubMed ID: 19680686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
    Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
    Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma.
    McCluggage WG; Jenkins D
    Int J Gynecol Pathol; 2003 Jul; 22(3):231-5. PubMed ID: 12819388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas.
    Ishikawa M; Fujii T; Masumoto N; Saito M; Mukai M; Nindl I; Ridder R; Fukuchi T; Kubushiro K; Tsukazaki K; Nozawa S
    Int J Gynecol Pathol; 2003 Oct; 22(4):378-85. PubMed ID: 14501820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma.
    Missaoui N; Hmissa S; Frappart L; Trabelsi A; Ben Abdelkader A; Traore C; Mokni M; Yaacoubi MT; Korbi S
    Virchows Arch; 2006 May; 448(5):597-603. PubMed ID: 16496173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations.
    Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G
    Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of S100A4, E-cadherin, alpha- and beta-catenin in gastric adenocarcinoma.
    Yoon CS; Hyung WJ; Lee JH; Chae YS; Won NH; Yeom BW; Choi JS
    Hepatogastroenterology; 2008; 55(86-87):1916-20. PubMed ID: 19102422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations.
    Negri G; Egarter-Vigl E; Kasal A; Romano F; Haitel A; Mian C
    Am J Surg Pathol; 2003 Feb; 27(2):187-93. PubMed ID: 12548164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of p16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri.
    Negri G; Bellisano G; Carico E; Faa G; Kasal A; Antoniazzi S; Egarter-Vigl E; Piccin A; Dalla Palma P; Vittadello F
    Int J Gynecol Pathol; 2011 Jul; 30(4):407-13. PubMed ID: 21623205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical Expression of the Tumor Suppressor Protein p16INK4a in Cervical Adenocarcinoma.
    Eleutério J; Lima TS; Cunha MD; Cavalcante DI; Silva AM
    Rev Bras Ginecol Obstet; 2017 Jan; 39(1):21-25. PubMed ID: 28245508
    [No Abstract]   [Full Text] [Related]  

  • 13. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms.
    Elishaev E; Gilks CB; Miller D; Srodon M; Kurman RJ; Ronnett BM
    Am J Surg Pathol; 2005 Mar; 29(3):281-94. PubMed ID: 15725796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papilloma virus (HPV) DNA detection.
    McCluggage WG
    Am J Surg Pathol; 2004 Jul; 28(7):974. PubMed ID: 15223971
    [No Abstract]   [Full Text] [Related]  

  • 15. P16 as a molecular biomarker of cervical adenocarcinoma.
    Schorge JO; Lea JS; Elias KJ; Rajanbabu R; Coleman RL; Miller DS; Ashfaq R
    Am J Obstet Gynecol; 2004 Mar; 190(3):668-73. PubMed ID: 15041997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem.
    Murphy N; Heffron CC; King B; Ganuguapati UG; Ring M; McGuinness E; Sheils O; O'Leary JJ
    Virchows Arch; 2004 Dec; 445(6):610-5. PubMed ID: 15378361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16INK4a overexpression independent of human papillomavirus infection in lobular endocervical glandular hyperplasia.
    Hashi A; Xu JY; Kondo T; Hashi K; Yuminamochi T; Nara M; Murata S; Katoh R; Hoshi K
    Int J Gynecol Pathol; 2006 Apr; 25(2):187-94. PubMed ID: 16633071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of p16INK4A mediated by beta-catenin in a TCF4-independent manner: implications for alterations in p16INK4A and pRb expression during trans-differentiation of endometrial carcinoma cells.
    Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
    Int J Cancer; 2006 Nov; 119(10):2294-303. PubMed ID: 16858682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
    Kong CS; Beck AH; Longacre TA
    Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.